MELVIN BANZON: Open Payments
NPI 1952925513 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$155 in 7 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $18 · 2025 $155
Food & beverage: $155
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $96 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: COBENFY, ABILIFY ASIMTUFII, TRINTELLIX, CAPLYTA.
Industry payments across NV — which companies pay providers there.
